Authors:
Passchier, J
van Waarde, A
Pieterman, RM
Elsinga, PH
Pruim, J
Hendrikse, HN
Willemsen, ATM
Vaalburg, W
Citation: J. Passchier et al., Quantitative imaging of 5-HT1A receptor binding in healthy volunteers with[F-18]p-MPPF, NUCL MED BI, 27(5), 2000, pp. 473-476
Authors:
Doze, P
Elsinga, PH
de Vries, EFJ
Van Waarde, A
Vaalburg, W
Citation: P. Doze et al., Mutagenic activity of a fluorinated analog of the beta-adrenoceptor ligandcarazolol in the Ames test, NUCL MED BI, 27(3), 2000, pp. 315-319
Authors:
Visser, TJ
van der Wouden, EA
van Waarde, A
Doze, P
Elsinga, PH
Vaalburg, W
Citation: Tj. Visser et al., Synthesis and biodistribution of [C-11]procaterol, a beta(2)-adrenoceptor agonist for positron emission tomography, APPL RAD IS, 52(4), 2000, pp. 857-863
Authors:
Doze, P
Van Waarde, A
Elsinga, PH
Hendrikse, NH
Vaalburg, W
Citation: P. Doze et al., Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrier, SYNAPSE, 36(1), 2000, pp. 66-74
Authors:
de Vries, EFJ
Luurtsema, G
Brussermann, M
Elsinga, PH
Vaalburg, W
Citation: Efj. De Vries et al., Fully automated synthesis module for the high yield one-pot preparation of6-[F-18]fluoro-L-DOPA, APPL RAD IS, 51(4), 1999, pp. 389-394
Authors:
Visser, TJ
van Waarde, A
Doze, P
Elsinga, PH
van der Mark, TW
Kraan, J
Ensing, K
Vaalburg, W
Citation: Tj. Visser et al., Characterisation of beta(2)-adrenoceptors, using the agonist [C-11]formoterol and positron emission tomography, EUR J PHARM, 361(1), 1998, pp. 35-41